WASHINGTON, Feb. 2, 2018 /PRNewswire-USNewswire/ — The 340B program was designed to increase access to medicines for vulnerable or uninsured patients through safety-net facilities, but all signs point to 340B doing the opposite – distorting the market and increasing health care costs for…
